Track topics on Twitter Track topics that are important to you
LOS ANGELES, Aug. 9, 2017 /PRNewswire/ -- Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against MAXIMUS, Inc. ("MAXIMUS" or the "Company") (NYSE: MMS) concerning possible violations of federal securities laws between October 30, 2014 and February 3, 2016, inclusive (the "Class Period"). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the October 6, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at firstname.lastname@example.org.
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the Complaint, throughout the Class Period, MAXIMUS made false and/or misleading statements and/or failed to disclose that: in obtaining the Health Assessment Advisory Service ("HAAS") contract, the Company set an unattainable target number of healthcare professionals to recruit and an unattainable target number of assessments; that throughout the HAAS contract, MAXIMUS was struggling to recruit, train and ramp-up new health care staff to perform the assessments; that the inability to meet its target number of healthcare recruits and target number of assessments, meant MAXIMUS would not earn the performance-based incentive fees from the HAAS contract; and that as a result, the Company's statements about its financial condition, and the outlook for its business, including statements about the HAAS contract and the amount of revenue MAXIMUS expected the contract to contribute, lacked a reasonable basis when made. Upon release of this information, shares of MAXIMUS fell in value materially, which caused investors harm according to the Complaint.
Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders' rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View original content:http://www.prnewswire.com/news-releases/important-shareholder-alert-lundin-law-pc-announces-a-securities-class-action-lawsuit-against-maximus-inc-and-encourages-investors-with-losses-to-contact-the-firm-300502419.html
SOURCE Lundin Law PCNEXT ARTICLE
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...